Cypress Growth Capital is one of the largest and most active royalty-based investment funds in the U.S.
Business Model: SAAS
Revenue: $17.1M
Employees: 2-10
Address: 3899 Maple Ave
City: Dallas
State: TX
Zip: 75219
Country: US
Cypress Growth Capital is the first, largest and most active royalty-based growth capital firm in the U.S., with $80,000,000 of committed capital across two funds. We provide an innovative, yet proven, source of funding for emerging and expanding companies. An alternative to traditional debt and equity instruments, royalty-based growth capital offers entrepreneurs access to significant capital while preserving equity and control. Cypress invests $1 million to $5 million in software and technology-enabled business services companies located in the Southwest with annual revenues between $3M and $20M. With available capital, a proven track record of twelve royalty-based investments, and an investment team that has extensive entrepreneurial and operating experience, Cypress Growth Capital is a proven and valued funding partner.
Contact Phone:
+12143047645
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2015 | Tiempo Development | Venture Round | 2.2M |
6/2013 | Circularenergy | Series A | 2.7M |
7/2021 | MedChat | Debt Financing | 0 |
8/2017 | ClearVoice | Grant | 0 |
7/2014 | Madwire | Series A | 5.5M |
11/2018 | Rehearsal | Venture Round | 0 |
6/2011 | Visualtising | Debt Financing | 1.5M |
12/2010 | Altitude Digital | Seed Round | 200k |
12/1999 | Conductus | Debt Financing | 15M |
1/2015 | ThermiAesthetics | Debt Financing | 9M |
10/2022 | HTX Labs | Seed Round | 3.2M |
5/2022 | ThoroughCare | Equity | 3M |
11/2019 | Stackify | Debt Financing | 0 |
2/2016 | zvelo | Post-IPO Equity | 2.8M |
10/2021 | Vision2Systems | Growth | 2.8M |
5/2021 | Selery | Venture Round | 2M |
2/2000 | Spatial | Series A | 6.9M |
9/2018 | FirstClose | Venture Round | - |
12/2014 | Advice Interactive Group | Series A | - |
6/2017 | ChartSpan Medical Technologies | Series A | 0 |
11/2016 | Greystone | Venture Round | 2M |
5/2016 | Dialexa | Seed Round | 2M |
7/2012 | GiftCard.com | Debt Financing | 3M |
2/2018 | Kingsmen Software | Series A | 2.5M |
5/2022 | ThoroughCare | Venture Round | 0 |
10/2021 | Vision2Systems | Venture Round | 0 |
7/2021 | MedChat | Debt Financing | 0 |
5/2021 | Selery | Debt Financing | 0 |
11/2019 | Stackify | Debt Financing | 0 |
11/2018 | Rehearsal | Venture Round | 0 |
9/2018 | FirstClose | Venture Round | - |
2/2018 | Kingsmen Software | Series A | 0 |
8/2017 | ClearVoice | Grant | 0 |
6/2017 | ChartSpan Medical Technologies | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|